Peripheral Arterial Disease: Features

ISET 2023

How IVUS Improves Clinical Outcomes; BELONG Study; Interpretation of BEST-CLI

02/23/2023

Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Eric Secemsky, MD, MSc, RPVI, FACC, F...

Dr. Eric Secemsky, from Beth Israel Deaconess Medical Center in Boston, Massachusetts, discusses his presentations from ISET 2023.

Dr. Eric Secemsky, from Beth...

02/23/2023

Vascular Disease Management

ISET 2023

Endograft Durability 30 Years Later; Results From the PROMISE II U.S. Pivotal Trial

02/23/2023

Daniel Clair, MD

Vanderbilt University Medical Center, Nashville, Tennessee

Daniel Clair, MD Vanderbilt Universi...

In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial.

In this video from ISET 2023,...

02/23/2023

Vascular Disease Management

Pharmacological Treatment of PAD Patients

ISET 2023

Pharmacological Treatment of PAD Patients: A Case-Based Discussion

02/17/2023

Ian Del Conde-Pozzi, MD, John Rundback, MD, and Eric Secemsky, MD, discuss this important topic.

Ian Del Conde-Pozzi, MD, John...

02/17/2023

Vascular Disease Management

Original Research

Examining Sex-Based Differences Among Individuals With Peripheral Arterial Disease in Southwest Louisiana: A Secondary Data Analysis

02/16/2023

Jennifer Lemoine, PhD, DNP, APRN¹; Barbara L. Wilson, PhD, RNC-OB, FAAN²; Katherine Sward, PhD, RN²; Richard J. Butler, PhD³

¹University of Louisiana at Lafayette, Lafayette, Louisiana; ²University of Utah, Salt Lake City, Utah; ³Brigham Young University, Provo, Utah

Jennifer Lemoine, PhD, DNP, APRN1; Ba...

Exploring the relationship between sex and determinants of PAD and symptom severity, treatments offered, and outcomes.

Exploring the relationship...

02/16/2023

Vascular Disease Management

Interview

Two-Year Results of the ILLUMINA Study: An Interview With Andrea Kahlberg, MD

01/19/2023

Andrea Kahlberg, MD

Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy

Andrea Kahlberg, MD Vita-Salute Univ...

VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.

VDM speaks with Dr. Andrea...

01/19/2023

Vascular Disease Management

ISET 2023

12-Month Results From the SWING Multicentre Study: A Novel Sirolimus-Coated Balloon for Use Below-the-Knee

01/18/2023

Written by Amanda Wright Harvey

Presented by Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), Prince of Wales Hospital, Sydney, Australia

Written by Amanda Wright Harvey Pres...

Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.

Dr. Ramon Varcoe presented...

01/18/2023

Vascular Disease Management

ISET 2023

LIBERTY Real-World Evidence on CLTI and Diabetic Patients

01/17/2023

Written by Amanda Wright Harvey

Presented by George Adams, MD MHS MBA FACC FSCAI, University of North Carolina REX Healthcare, Raleigh, North Carolina

Written by Amanda Wright Harvey Pres...

In a session from Tuesday, George Adams, MD, MHS, MBA, FACC, FSCAI, from UNC REX Hospital in Raleigh, North Carolina, presented results from the LIBERTY 360 analysis on patients with chronic limb-threatening ischemia.

In a session from Tuesday,...

01/17/2023

Vascular Disease Management

ISET 2023

Reintervention Patterns Among Patients With In-Stent Restenosis, Long Lesions, and Chronic Total Occlusions

01/17/2023

Written by Amanda Wright Harvey

Presented by Gunnar Tepe, MD, RoMed Hospital, Rosenheim, Germany

Written by Amanda Wright Harvey Pres...

On Tuesday, Gunnar Tepe, MD, from RoMed Hospital in Rosenheim, Germany, provided attendees with an update on reintervention patterns in patients with in-stent restenosis, long lesions, and chronic total occlusions.

On Tuesday, Gunnar Tepe, MD,...

01/17/2023

Vascular Disease Management

ISET 2023

12-Month Outcomes With a Paclitaxel DES: Highlighting the Impact of Vessel Sizing

01/17/2023

Presented by Venita Chandra, MD, Stanford University, Stanford, California

Presented by Venita Chandra, MD, Stan...

In a Tuesday ISET 2023 session, Venita Chandra, MD, from Stanford University in Stanford, California, presented study results on the use of paclitaxel with a drug-eluting stent (DES) and the importance of vessel sizing.

In a Tuesday ISET 2023 session,...

01/17/2023

Vascular Disease Management

ISET 2023

MIMICS-3D 3-Year Outcomes in Complex Lesions

01/17/2023

Written by Amanda Wright Harvey

Presented by Robert E. Beasley, MD, FSIR, FSCAI, Palm Vascular Centers, Miami Beach, Florida

Written by Amanda Wright Harvey Pres...

At Tuesday's ISET 2023 sessions, Dr. Robert Beasley presented 3-year results of MIMICS, a prospective, multicenter, observational study that evaluated BioMimics 3D in 507 patients with peripheral arterial disease at 23 investigational sites...

At Tuesday's ISET 2023 sessions,...

01/17/2023

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Sleep and CVD

Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells

08/06/2024

After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...

After just six weeks of...

08/06/2024

Cath Lab Digest

Peripheral Interventions

VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management

07/30/2024

The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...

The FLEX Vessel Prep System has...

07/30/2024

Cath Lab Digest

Peripheral Interventions

Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure

07/30/2024

Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...

Transit Scientific, a...

07/30/2024

Cath Lab Digest

Carotid Artery Revascularization

Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures

07/30/2024

Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...

Transcarotid Artery...

07/30/2024

Cath Lab Digest

Health Care Needs

JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality

07/29/2024

Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...

Upon analyzing all 3,143 U.S....

07/29/2024

Cath Lab Digest

Renal Denervation

First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation

07/25/2024

The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...

The study will focus on...

07/25/2024

Cath Lab Digest

Ischemic Stroke

Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke

07/24/2024

“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...

“The observed data showed all...

07/24/2024

Cath Lab Digest

News

HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025

07/22/2024

LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.

LINC, the world’s premier...

07/22/2024

Vascular Disease Management

News

Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology

07/17/2024

More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology

More than $274,000 in NSF...

07/17/2024

Vascular Disease Management

Ischemic Stroke

Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke

07/17/2024

Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.

Based on physician feedback, the...

07/17/2024

Cath Lab Digest

Peripheral Arterial Disease: Features

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products